ERRATA Erratum for "Utility of Isoproterenol to Provoke Outflow Tract Gradients in Patients with
Hypertrophic Cardiomyopathy" Am J Cardiol 2008; 101:516-520 We recently found an error manuscript "Utility of Isoproterenol to Provoke Outflow Tract Gradients in Patients with Hypertrophic Cardiomyopathy" which was published in the American Journal of Cardiology 2008;101:516-520. We would like to publish an erratum to call attention to this error; specifically for the safety of patients undergoing this type of intervention.
In the Methods section, we had stated in the third paragraph that "the isoproterenol infusion was started at 1 mg/kg/ min and increase at 3-minute intervals up to 4 mg/kg/min."
This was an error on our part, as the isoproterenol dosage should be 1 mg/min increasing up to 4 mg/min.
We do apologize for this error and would appreciate having the AJC publish an erratum, in order to prevent medication errors from occurring in patients undergoing this procedure.
Thank you in advance for your attention to this matter. Our study, Lesion-Specific Factors Contributing to In-hospital Costs in Adults With Congenital Heart Disease published June 2016 in The American Journal of Cardiology, is an analysis of the State Inpatient Database (SID), a restricted-access, publicly available dataset that is maintained by the Agency for Healthcare Research and Quality (AHRQ). One of the provisions of the SID Data Use Agreement (DUA), which I signed when purchasing the data, is that no data observation involving less than or equal to 10 observations is to be published. This measure was put in place by AHRQ to protect individual patients' privacy and to prevent the potential disclosure of personal information. In our manuscript, there are some tabulated cells that are in violation of this provision. This represents an oversight on my part and an inadvertent failure to comply with the Data Use Agreement. For this, I apologize. While I am fully confident that nothing in our paper could be used to identify individuals or their personal information, the fact remains that the disclosures are in violation of the AHRQ guidelines. We have therefore asked the editors of The American Journal of Cardiology to post a revised online version of our paper that is in compliance with the AHRQ guidelines, and request that, going forward, authors cite the corrected version of our manuscript. 
